|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating activities | ||
| Net (loss) income | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Change in fair value of warrant liability | ||
| Gain on warrant termination | ||
| Reversal of warrant contract asset amortization | ||
| Stock-based compensation | ||
| Gain on warrant exercise | ||
| Gain on marketable equity securities | ||
| Loss on disposal of property and equipment | ||
| Loss on debt extinguishment | ||
| Deferred income taxes | ||
| Losses from equity method investments | ||
| Amortization of original issue discount | ||
| Amortization of deferred financing fees | ||
| Change in fair value of contingent consideration | ||
| Change in fair value of holdback liability | ||
| Amortization of warrant contract asset | ||
| Depreciation and amortization | ||
| Provision for bad debt expense | ||
| Provision for obsolete inventory | ||
| Amortization of finance right-of-use lease assets | ||
| Change in fair value of warrant asset | ||
| Non-cash operating lease costs | ||
| Minimum accretion expense | ||
| Impairment of intangible assets | ||
| PIK interest added to principal | ||
| Change in assets and liabilities | ||
| Accounts receivable | ||
| Inventory | ||
| Prepaid expenses and other current assets | ||
| Investments and other assets | ||
| Accounts payable | ||
| Related party asset | ||
| Deferred revenue | ||
| Deferred other income | ||
| Accrued data licensing fees | ||
| Accrued expenses & other | ||
| Interest payable | ||
| Operating lease liabilities | ||
| Net cash used in operating activities | ||
| Investing activities | ||
| Purchases of property and equipment | ||
| Proceeds from sale of marketable equity securities | ||
| Purchases of marketable equity securities | ||
| Business combinations, net of cash acquired | ||
| Investment in joint venture | ||
| Capitalized software costs | ||
| Net cash used in investing activities | ||
| Financing activities | ||
| Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions | ||
| Tax withholding related to net share settlement of restricted stock units | ||
| Issuance of Series G-4 Preferred Stock, net of offering costs | ||
| Series G-3 Redeemable Convertible Preferred Stock | ||
| Series G-4 Redeemable Convertible Preferred Stock | ||
| Total issuance of Series G-4 Preferred Stock, net of offering costs | ||
| Issuance of Series G-5 Preferred Stock | ||
| Principal payments on finance lease liabilities | ||
| Purchase of treasury stock | ||
| Payment of deferred offering costs | ||
| Dividends paid | ||
| Proceeds from revolving credit facility, net of original issue discount | ||
| Proceeds from long-term debt, net of original issue discount | ||
| Proceeds from convertible senior notes, net of initial purchasers' discount | ||
| Payment of deferred financing fees | ||
| Payment of indemnity holdback related to acquisition | ||
| G-4 Special Payment | ||
| Principal payments on long-term debt | ||
| Prepayment premium on long-term debt | ||
| Purchases of capped call | ||
| Proceeds from issuance of common stock in connection with at-the-market offering, net of commissions | ||
| Net cash provided by financing activities | ||
| Effect of foreign exchange rates on cash | ||
| Net increase (decrease) in Cash, Cash Equivalents and Restricted Cash | ||
| Cash, cash equivalents and restricted cash, beginning of period | ||
| Cash, cash equivalents and restricted cash, end of period | ||
| Supplemental disclosure of cash flow information | ||
| Cash paid during the year for interest | ||
| Cash paid for income taxes | ||
| Marketable equity securities received on accounts receivable | ||
| Supplemental disclosure of noncash investing and financing activities | ||
| Dividends Payable | ||
| Purchases of property and equipment, accrued but not paid | ||
| Redemption of convertible promissory note | ||
| Non-voting common stock issued in connection with business combinations | ||
| Non-voting common stock issued in connection with contingent consideration | ||
| Accretion of convertible preferred stock to redemption value | ||
| Deferred offering costs, accrued but not yet paid | ||
| Deferred financing fees, accrued but not yet paid | ||
| Reclassification of deferred offering costs to additional paid-in capital upon at-the-market offering | ||
| Operating lease liabilities arising from obtaining right-of-use assets | ||
| Finance lease liabilities arising from obtaining right-of-use-assets | ||
| Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | ||
| Taxes related to net share settlement of restricted stock units not yet paid | ||
| Reclassification of deferred offering costs to additional paid-in capital upon initial public offering | ||
| Class A Common Stock issued in connection with business combinations | ||
| Class A Common Stock issued in connection with license agreement | ||
| Issuance of Series | ||
| Series G-3 Redeemable Convertible Preferred Stock | ||
| Series G-4 Redeemable Convertible Preferred Stock | ||
| Issuance of warrant | ||
| Issuance of common stock in connection with contingent consideration | ||
| Convertible promissory note principal reset due to amendment | ||
| Cash, Cash Equivalents and Restricted Cash are Comprised of: | ||
| Cash and cash equivalents | ||
| Restricted cash and cash equivalents | ||
| Restricted cash |
Loading...
